Skip to Content

269 Results Found

  • Article
  • Open Access
1,287 Views
13 Pages

27 May 2025

Early determination of the Shiga toxin type of Shiga toxin-producing Escherichia coli (STEC) is crucial for guiding STEC-infected patients for proper and timely treatment and patient care. Most diagnostic microbiology laboratories rely on PCR assays...

  • Article
  • Open Access
4 Citations
2,019 Views
13 Pages

Mitomycin C as an Anti-Persister Strategy against Klebsiella pneumoniae: Toxicity and Synergy Studies

  • Olga Pacios,
  • Soraya Herrera-Espejo,
  • Lucía Armán,
  • Clara Ibarguren-Quiles,
  • Lucía Blasco,
  • Inés Bleriot,
  • Laura Fernández-García,
  • Concha Ortiz-Cartagena,
  • María Paniagua and
  • María Tomás
  • + 4 authors

The combination of several therapeutic strategies is often seen as a good way to decrease resistance rates, since bacteria can more easily overcome single-drug treatments than multi-drug ones. This strategy is especially attractive when several targe...

  • Article
  • Open Access
1 Citations
2,074 Views
11 Pages

Mitomycin C in Ahmed Glaucoma Valve Implant Affects Surgical Outcomes

  • Wei-Chun Lin,
  • Sen Yang,
  • Michelle R. Hribar and
  • Aiyin Chen

Glaucoma is the leading cause of irreversible blindness worldwide, and the Ahmed Glaucoma Valve (AGV) implant is one of the most commonly performed surgeries to prevent glaucoma-related visual impairment. Mitomycin C is an anti-fibrotic agent that ma...

  • Article
  • Open Access
3 Citations
2,874 Views
14 Pages

Determination of the Protein-Protein Interactions within Acyl Carrier Protein (MmcB)-Dependent Modifications in the Biosynthesis of Mitomycin

  • Dongjin Leng,
  • Yong Sheng,
  • Hengyu Wang,
  • Jianhua Wei,
  • Yixin Ou,
  • Zixin Deng,
  • Linquan Bai and
  • Qianjin Kang

10 November 2021

Mitomycin has a unique chemical structure and contains densely assembled functionalities with extraordinary antitumor activity. The previously proposed mitomycin C biosynthetic pathway has caused great attention to decipher the enzymatic mechanisms f...

  • Article
  • Open Access
1,016 Views
13 Pages

Effectiveness and Safety of Mitomycin C in Deep Sclerectomy with the Esnoper Clip Implant: A Case Series Study

  • Rachid Bouchikh-El Jarroudi,
  • Alina-Dana Baxant,
  • Pavel Studeny,
  • Kolbe Roche Fernández,
  • Adrian Sanchez-Fortun-Sanchez,
  • Martin Pencak,
  • Jessica Botella-Garcia,
  • Jordi Loscos-Arenas,
  • Antoni Sabala Llopart and
  • Pau Romera-Romero
  • + 1 author

28 August 2025

Objective: The objective was to provide evidence on the effectiveness (intraocular pressure, IOP) and safety of Deep Sclerectomy with the Esnoper Clip implant with and without the use of mitomycin C (MMC) in uncontrolled primary open-angle glaucoma....

  • Article
  • Open Access
869 Views
15 Pages

Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial

  • Peter Oppelt,
  • Jessica Ley,
  • Christine Auberle,
  • Brendan Knapp,
  • Jesse Zaretsky,
  • Fei Wan and
  • Douglas Adkins

4 November 2025

Background/Objectives: Functional p53 is critical for anti-tumor activity of mitomycin-C. In wild-type TP53 human papillomavirus (HPV)-positive squamous cell carcinoma (SCC) cell lines, mitomycin-C repressed E6 oncoprotein expression and induced p53,...

  • Article
  • Open Access
6 Citations
3,670 Views
24 Pages

Electrochemotherapy with Mitomycin C Potentiates Apoptosis Death by Inhibiting Autophagy in Squamous Carcinoma Cells

  • Maria Condello,
  • Gloria D’Avack,
  • Rosa Vona,
  • Enrico Pierluigi Spugnini,
  • Licia Scacco and
  • Stefania Meschini

31 July 2021

We investigated the chemosensitizing effect of electroporation (EP), which, using electrical pulses, permeabilizes cancer cells to drugs. The study involved two human hypopharyngeal and tongue carcinoma cell lines. The surface and intracytoplasmic ex...

  • Feature Paper
  • Article
  • Open Access
744 Views
14 Pages

Submucosal Mitomycin C Injection in the Endoscopic Treatment of Laryngotracheal Stenosis: Experience of a Tertiary Center

  • Elena Russo,
  • Luca Canali,
  • Luca Cerri,
  • Giuseppe Mangiameli,
  • Umberto Cariboni,
  • Giuseppe Marulli,
  • Giuseppe Spriano,
  • Giorgio Maria Ferraroli and
  • Armando De Virgilio

12 November 2025

Background/Objectives: To assess the safety and efficacy of submucosal mitomycin C (MMC) injection as an adjunct in patients undergoing endoscopic treatment for laryngotracheal stenosis (LTS). Methods: All patients affected by LTS receiving endoscopi...

  • Article
  • Open Access
15 Citations
3,330 Views
14 Pages

Use of Self-Assembled Colloidal Prodrug Nanoparticles for Controlled Drug Delivery of Anticancer, Antifibrotic and Antibacterial Mitomycin

  • Mohamed M. Abdelghafour,
  • Ágota Deák,
  • Diána Szabó,
  • Imre Dékány,
  • László Rovó and
  • László Janovák

Herein we present the synthesis of a polymeric prodrug nanomaterial capable of spontaneous, self-assembled nanoparticle formation and of the conjugation (encapsulation) of drugs with amino and/or carboxyl and/or hydroxyl groups via ester and/or amide...

  • Article
  • Open Access
1,289 Views
9 Pages

The Effect of Different Intraperitoneal Hyperthermic Chemotherapy (HIPEC) Regimens on Serum Electrolyte Levels: A Comparison of Oxaliplatin and Mitomycin C

  • Vural Argın,
  • Mehmet Ömer Özduman,
  • Ahmet Orhan Sunar,
  • Mürşit Dinçer,
  • Aziz Serkan Senger,
  • Selçuk Gülmez,
  • Orhan Uzun,
  • Mustafa Duman and
  • Erdal Polat

25 July 2025

Background and Objectives: This study aimed to compare the effects of HIPEC procedures using oxaliplatin and mitomycin C on serum electrolyte, glucose, and lactate levels, with a specific focus on the carrier solutions employed. Materials and Methods...

  • Article
  • Open Access
2 Citations
2,933 Views
14 Pages

21 January 2023

Background: The drug selection of radical surgery (RS), with hyperthermic intraperitoneal chemotherapy (HIPEC), in pT4 colorectal cancer (CRC) remains controversial. Methods: Adverse events after HIPEC were estimated by common terminology criteria fo...

  • Article
  • Open Access
943 Views
14 Pages

2 September 2025

Lignin, the second most abundant biopolymer in nature after cellulose, has attracted attention for its compatibility with carbon-based materials. In this study, lignin-modified single-use pencil graphite electrodes (PGE/LG) were developed for the ele...

  • Article
  • Open Access
7 Citations
7,908 Views
14 Pages

Effect and Mechanism of Mitomycin C Combined with Recombinant Adeno-Associated Virus Type II against Glioma

  • Hong Ma,
  • Yunjia Zhang,
  • Hailong Wang,
  • Chuanhui Han,
  • Runhong Lei,
  • Lei Zhang,
  • Zuye Yang,
  • Ling Rao,
  • Hong Qing and
  • Yulin Deng
  • + 1 author

19 December 2013

The effect of chemotherapy drug Mitomycin C (MMC) in combination with recombinant adeno-associated virus II (rAAV2) in cancer therapy was investigated, and the mechanism of MMC affecting rAAV2’s bioactivity was also studied. The combination effect wa...

  • Article
  • Open Access
5 Citations
3,284 Views
13 Pages

The Controlled Release and Prevention of Abdominal Adhesion of Tannic Acid and Mitomycin C-Loaded Thermosensitive Gel

  • Youping Li,
  • Gaixia Liu,
  • Mengting Wang,
  • Yuling Zhang,
  • Shiwan You,
  • Jing Zhang,
  • Gang Guo,
  • Bo Han,
  • Le Li and
  • Na Zhao

16 February 2023

Postoperative abdominal adhesion is one of the most common complications after abdominal surgery. A single drug or physical barrier treatment does not achieve the ideal anti-adhesion effect. We developed a thermosensitive hydrogel (PPH hydrogel) cons...

  • Article
  • Open Access
19 Citations
3,373 Views
16 Pages

Elevated Expression of Toxin TisB Protects Persister Cells against Ciprofloxacin but Enhances Susceptibility to Mitomycin C

  • Daniel Edelmann,
  • Florian H. Leinberger,
  • Nicole E. Schmid,
  • Markus Oberpaul,
  • Till F. Schäberle and
  • Bork A. Berghoff

Bacterial chromosomes harbor toxin-antitoxin (TA) systems, some of which are implicated in the formation of multidrug-tolerant persister cells. In Escherichia coli, toxin TisB from the tisB/istR-1 TA system depolarizes the inner membrane and causes A...

  • Article
  • Open Access
16 Citations
4,928 Views
16 Pages

26 December 2020

(1) Background: Mitomycin C (MMC) is commonly used during trabeculectomy. However, there is no consensus on which concentration should be used. We aimed to compare the efficacy and safety of 0.2 mg/mL and 0.4 mg/mL of MMC in eyes undergoing trabecule...

  • Case Report
  • Open Access
1 Citations
4,176 Views
6 Pages

Purpose: To present a case of delayed onset scleromalacia and conjunctival bleb formation one year after conjunctival melanoma excision with intraoperative use of mitomycin-C (MMC) and double-freeze-thaw technique. Methods: Case report. Results: A 69...

  • Article
  • Open Access
3 Citations
2,699 Views
16 Pages

Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib

  • Gehan Botrus,
  • Denise Roe,
  • Gayle S. Jameson,
  • Pedro Luiz Serrano Uson Junior,
  • Ronald Lee Korn,
  • Lana Caldwell,
  • Taylor Bargenquast,
  • Max Miller and
  • Erkut Hasan Borazanci

Recent efforts to personalize treatment with platinum-based chemotherapy and PARP inhibitors have produced promising results in homologous recombinant deficient (HRD) metastatic pancreatic cancer (MPC). However, new strategies are necessary to overco...

  • Article
  • Open Access
1,989 Views
23 Pages

Variations in Circulating Tumor Microenvironment-Associated Proteins in Non-Muscle Invasive Bladder Cancer Induced by Mitomycin C Treatment

  • Benito Blanco Gómez,
  • Francisco Javier Casas-Nebra,
  • Daniel Pérez-Fentes,
  • Susana B. Bravo,
  • Laura Rodríguez-Silva and
  • Cristina Núñez

Mitomycin C (MMC) is a widely employed chemotherapeutic agent, particularly in non-muscle invasive bladder cancer (NMIBC), where it functions by inducing DNA cross-linking and promoting tumor cell apoptosis. However, the tumor microenvironment (TME)...

  • Article
  • Open Access
10 Citations
2,905 Views
12 Pages

11 May 2021

Conjunctival wound healing determines success after filtration surgery and the quest for better antifibrotic agents remains active. This study compares intracameral bevacizumab to sub-Tenon’s mitomycin C (MMC) in trabeculectomy. Primary open-angle or...

  • Article
  • Open Access
4 Citations
4,875 Views
8 Pages

23 December 2021

Background and Objectives: To report the long-term outcomes of patients with refractory Vernal Keratoconjunctivitis (VKC) who underwent surgical excision of giant papillae (GP) with mitomycin C (MMC) 0.02% and amniotic membrane transplantation (AMT)....

  • Article
  • Open Access
14 Citations
7,841 Views
18 Pages

15 September 2014

In order to explore the synergistic mechanisms of combinatorial treatment using curcumin and mitomycin C (MMC) for breast cancer, MCF-7 breast cancer xenografts were conducted to observe the synergistic effect of combinatorial treatment using curcumi...

  • Article
  • Open Access
23 Citations
8,672 Views
11 Pages

17 February 2012

Combined therapy emerges as an attractive strategy for cancer treatment. The aim of this study was to investigate the inhibitory effects of mitomycin C (MMC) combined with a novel antibody fragment (Fab) targeting latent membrane protein 1 (LMP1) on...

  • Article
  • Open Access
20 Citations
6,252 Views
18 Pages

26 April 2018

The use of phototherapy as an adjuvant bladder cancer treatment has long been considered, but its application has been severely hampered due to a lack of tumor specificity, unpredicted cytotoxicity, and insufficient anticancer efficacy. In this study...

  • Article
  • Open Access
58 Citations
7,039 Views
21 Pages

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines

  • Roxan F.C.P.A. Helderman,
  • Daan R. Löke,
  • Jan Verhoeff,
  • Hans M. Rodermond,
  • Gregor G.W. van Bochove,
  • Menno Boon,
  • Sanne van Kesteren,
  • Juan J. Garcia Vallejo,
  • H. Petra Kok and
  • Arlene L. Oei
  • + 3 authors

25 July 2020

Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment with curative intent for peritoneal metastasis of colorectal cancer (CRC). Currently, there is no standardized HIPEC protocol: choice of drug, pe...

  • Feature Paper
  • Article
  • Open Access
10 Citations
3,714 Views
16 Pages

Cancer is one of the most devastating diseases that leads to a high degree of mortality worldwide. Hence, extensive efforts have been devoted to the development of drug nanocarrier vectors as a potential new cancer treatment option. The main goal of...

  • Article
  • Open Access
32 Citations
5,024 Views
19 Pages

Drug Release Profiles of Mitomycin C Encapsulated Quantum Dots–Chitosan Nanocarrier System for the Possible Treatment of Non-Muscle Invasive Bladder Cancer

  • Fariza Aina Abd Manan,
  • Nor Azah Yusof,
  • Jaafar Abdullah,
  • Faruq Mohammad,
  • Armania Nurdin,
  • Latifah Saiful Yazan,
  • Sachin K. Khiste and
  • Hamad A. Al-Lohedan

Nanotechnology-based drug delivery systems are an emerging technology for the targeted delivery of chemotherapeutic agents in cancer therapy with low/no toxicity to the non-cancer cells. With that view, the present work reports the synthesis, charact...

  • Article
  • Open Access
28 Citations
5,010 Views
15 Pages

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain

  • Ana Plata,
  • Félix Guerrero-Ramos,
  • Carlos Garcia,
  • Alejandro González-Díaz,
  • Ignacio Gonzalez-Valcárcel,
  • José Manuel de la Morena,
  • Francisco Javier Díaz-Goizueta,
  • Julio Fernández del Álamo,
  • Victoria Gonzalo and
  • Javier C. Angulo
  • + 10 authors

30 October 2021

(1) Background: Intravesical mitomycin-C (MMC) combined with hyperthermia is increasingly used in non-muscle invasive bladder cancer (NMIBC), especially in the context of a relative BCG shortage. We aim to determine real-world data on the long-term t...

  • Article
  • Open Access
2 Citations
3,479 Views
10 Pages

Long-Term Outcomes of Intravesical Mitomycin C Administered via Electromotive Drug Administration or Conductive Chemo-Hyperthermia in Non-Muscle-Invasive Bladder Cancer

  • Maria Teresa Melgarejo-Segura,
  • Alberto Zambudio-Munuera,
  • Miguel Ángel Arrabal-Polo,
  • Pablo Lardelli-Claret,
  • Manuel Pareja-Vilchez and
  • Miguel Arrabal-Martín

28 January 2025

Background/Objectives: Non-muscle-invasive bladder cancer (NMIBC) is a common form of bladder cancer with a significant risk of recurrence and progression, especially in intermediate- and high-risk patients. Bacillus Calmette–Guérin (BCG...

  • Article
  • Open Access
11 Citations
3,520 Views
22 Pages

Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer

  • Lingling Qi,
  • Chao Liu,
  • Yingying Zhang,
  • Zheao Zhang,
  • Hongxia Duan,
  • Heming Zhao,
  • Xin Xin,
  • Liqing Chen,
  • Mingji Jin and
  • Wei Huang
  • + 2 authors

Micelle is mainly used for drug delivery and is prepared from amphiphilic block copolymers. It can be formed into an obvious core-shell structure that can incorporate liposoluble drugs. However, micelles are not suitable for the encapsulation of wate...

  • Systematic Review
  • Open Access
6 Citations
5,984 Views
19 Pages

10 December 2024

Background: Non-muscle-invasive bladder cancer (NMIBC) comprises about 75% of all bladder cancers. Although NMIBC is treatable, it poses significant costs and burdens to patients due to high recurrence rates. We conducted an updated meta-analysis of...

  • Article
  • Open Access
212 Views
17 Pages

29 January 2026

Intimal hyperplasia (IH) at vascular anastomosis sites arises from endothelial injury, thrombin activation, and the subsequent proliferation and phenotypic modulation of vascular smooth muscle cells (VSMCs). Existing clinically used systemic pharmaco...

  • Article
  • Open Access
5 Citations
3,410 Views
12 Pages

Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer

  • Laurent Mineur,
  • Léa Vazquez,
  • Mohamed Belkacemi,
  • Clémence Toullec,
  • Newfel Bentaleb,
  • Rania Boustany and
  • Frederi Plat

18 September 2023

Since EXTRA, a non-randomized phase II trial with 31 patients, explored the use of capecitabine, mitomycin and radiation therapy (RT) in the treatment of localized squamous cell carcinoma of the anal canal (SCCAC), this treatment has been considered...

  • Article
  • Open Access
1 Citations
1,670 Views
14 Pages

Acid Sphingomyelinase Activation and ROS Generation Potentiate Antiproliferative Effects of Mitomycin in HCC

  • Sirkka Buitkamp,
  • Stephanie Schwalm,
  • Katja Jakobi,
  • Nerea Ferreiros,
  • Christin Wünsche,
  • Stefan Zeuzem,
  • Erich Gulbins,
  • Christoph Sarrazin,
  • Josef Pfeilschifter and
  • Georgios Grammatikos

13 November 2024

Sphingolipids play a major role in the regulation of hepatocellular apoptosis and proliferation. We have previously identified sphingolipid metabolites as biomarkers of chronic liver disease and hepatocellular carcinoma. Human hepatocellular carcinom...

  • Article
  • Open Access
10 Citations
3,280 Views
10 Pages

2 March 2022

We compared 1-year outcomes of trabeculectomy with mitomycin C (MMC) and Ahmed valve implantation with MMC as a first surgical procedure in patients with uveitic glaucoma. A total 38 eyes of 38 patients undergoing trabeculectomy (n =16) or Ahmed valv...

  • Article
  • Open Access
11 Citations
3,493 Views
15 Pages

10 February 2024

The aims of this study were (i) to determine if the combination of mitomycin C with pentamidine or existing antibiotics resulted in enhanced efficacy versus infections with MDR P. aeruginosa in vivo; and (ii) to determine if the doses of mitomycin C...

  • Article
  • Open Access
13 Citations
2,894 Views
13 Pages

Assessment of a Coated Mitomycin-Releasing Biodegradable Ureteral Stent as an Adjuvant Therapy in Upper Urothelial Carcinoma: A Comparative In Vitro Study

  • Federico Soria,
  • Salvador David Aznar-Cervantes,
  • Julia E. de la Cruz,
  • Alberto Budia,
  • Javier Aranda,
  • Juan Pablo Caballero,
  • Álvaro Serrano and
  • Francisco Miguel Sánchez Margallo

28 July 2022

A major limitation of the treatment of low-grade upper tract urothelial carcinoma is the difficulty of intracavitary instillation of adjuvant therapy. Therefore, the aim of this in vitro study was to develop and to assess a new design of biodegradabl...

  • Article
  • Open Access
8 Citations
2,679 Views
9 Pages

Cytotoxicity Assessment of a New Design for a Biodegradable Ureteral Mitomycin Drug-Eluting Stent in Urothelial Carcinoma Cell Culture

  • Federico Soria,
  • Luna Martínez-Pla,
  • Salvador D. Aznar-Cervantes,
  • Julia E. de la Cruz,
  • Tomás Fernández,
  • Daniel Pérez-Fentes,
  • Luis Llanes and
  • Francisco Miguel Sánchez-Margallo

29 September 2022

Urothelial tumour of the upper urinary tract is a rare neoplasm, but unfortunately, it has a high recurrence rate. The reduction of these tumour recurrences could be achieved by the intracavitary instillation of adjuvant chemotherapy after nephron-sp...

  • Article
  • Open Access
1 Citations
2,584 Views
10 Pages

Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil

  • Alyssa K. DeZeeuw,
  • Michael F. Bassetti,
  • Evie H. Carchman,
  • Charles P. Heise,
  • Dana Hayden,
  • Elise H. Lawson,
  • Cristina B. Sanger,
  • Ray King,
  • Noelle K. LoConte and
  • Dustin A. Deming
  • + 2 authors

3 September 2024

Background: Although squamous cell carcinoma of the anus (SCCA) is a relatively uncommon malignancy in the United States, it continues to increase in incidence. Treatment for locoregional disease includes mitomycin and 5-fluorouracil with radiation....

  • Article
  • Open Access
10 Citations
11,194 Views
14 Pages

Amifostine Protection Against Mitomycin-induced Chromosomal Breakage in Fanconi Anaemia Lymphocytes

  • Ricardo M. Camelo,
  • Fernanda S. G. Kehdy,
  • Carlos E. Salas and
  • Miriam T. P. Lopes

21 August 2008

Fanconi anaemia (FA) is a rare genetic chromosomal instability syndrome caused by impairment of DNA repair and reactive oxygen species (ROS) imbalance. This disease is also related to bone marrow failure and cancer. Treatment of these complications w...

  • Article
  • Open Access
1 Citations
2,839 Views
9 Pages

Predictive Value of Bleb Vascularity after Mitomycin C Augmented Trabeculectomy

  • Aleksandra Wlaź,
  • Anna Kuna,
  • Agnieszka Wilkos-Kuc,
  • Agnieszka Rozegnał-Madej,
  • Tin Aung and
  • Tomasz Żarnowski

29 October 2020

Background: To evaluate the relationship between bleb vascularity and surgical outcome one year after mitomycin C (MMC) augmented trabeculectomy. Methods: This was a prospective study of 51 eyes of 44 patients after MMC-augmented primary trabeculecto...

  • Article
  • Open Access
1 Citations
3,821 Views
15 Pages

BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents

  • Zida Zhu,
  • Taisuke Kitano,
  • Masami Morimatsu,
  • Arisa Tanaka,
  • Ryo Morioka,
  • Xianghui Lin,
  • Koichi Orino and
  • Yasunaga Yoshikawa

Breast cancer type 2 susceptibility (BRCA2) protein is crucial for initiating DNA damage repair after chemotherapy with DNA interstrand crosslinking agents or X-ray irradiation, which induces DNA double-strand breaks. BRCA2 contains a C-terminal RAD5...

  • Article
  • Open Access
943 Views
14 Pages

14 July 2025

Trabeculectomy with mitomycin C is a key surgical intervention for managing glaucoma when conservative treatments fail. The success of trabeculectomy is influenced by various factors, including preoperative ocular characteristics like conjunctival va...

  • Communication
  • Open Access
4 Citations
2,773 Views
13 Pages

Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C

  • Maxim Sinitsky,
  • Maxim Asanov,
  • Anna Sinitskaya,
  • Daria Shishkova,
  • Maria Khutornaya,
  • Varvara Minina and
  • Anastasia Ponasenko

HMG-CoA reductase inhibitors (statins) are widely used in the therapy of atherosclerosis and have a number of pleiotropic effects, including DNA repair regulation. We studied the cytogenetic damage and the expression of DNA repair genes (DDB1, ERCC4,...

  • Article
  • Open Access
9 Citations
4,405 Views
16 Pages

Moderate Seasonal Dynamics Indicate an Important Role for Lysogeny in the Red Sea

  • Ruba Abdulrahman Ashy,
  • Curtis A. Suttle and
  • Susana Agustí

Viruses are the most abundant microorganisms in marine environments and viral infections can be either lytic (virulent) or lysogenic (temperate phage) within the host cell. The aim of this study was to quantify viral dynamics (abundance and infection...

  • Article
  • Open Access
4 Citations
1,606 Views
12 Pages

Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma

  • Ian M. McElree,
  • Vignesh T. Packiam,
  • Ryan L. Steinberg,
  • Helen Y. Hougen,
  • Mohamad Abou Chakra,
  • Sarah L. Mott and
  • Michael A. O’Donnell

10 December 2024

Background: After first-line treatment failure, patients with non-muscle invasive urothelial carcinoma (NMIUC) are recommended to undergo radical cystectomy. However, those unable to pursue radical surgery or desiring bladder preservation require eff...

  • Article
  • Open Access
25 Citations
1,121 Views
8 Pages

One Compared with Two Cycles of Mitomycin C in Chemoradiotherapy for Anal Cancer: Analysis of Outcomes and Toxicity

  • R. Yeung,
  • Y. McConnell,
  • G. Roxin,
  • R. Banerjee,
  • G.B. Roldán Urgoiti,
  • A.R. MacLean,
  • W.D. Buie,
  • K.E. Mulder,
  • M.M. Vickers and
  • C.M. Doll
  • + 1 author

1 June 2014

(1) Background: Concurrent chemoradiation with fluorouracil (5fu) and mitomycin C (mmc) is standard treatment for anal canal carcinoma (acc). The current protocol in Alberta is administration of 5fu and mmc during weeks 1 and 5 of radiation. However,...

  • Article
  • Open Access
5 Citations
3,716 Views
10 Pages

29 December 2021

Recent advances in ocular aberrometry have revealed that ocular surgery increases ocular and corneal higher-order aberrations. This retrospective single-center study aimed to examine the effects of the overhanging bleb on corneal higher-order aberrat...

  • Article
  • Open Access
21 Citations
5,076 Views
17 Pages

15 July 2020

The lytic and lysogenic life cycles of marine phages are influenced by environmental conditions such as solar radiation, temperature, and host abundance. Temperature can regulate phage infection, but its role is difficult to discern in oligotrophic w...

  • Article
  • Open Access
4 Citations
3,151 Views
14 Pages

Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C

  • Emika Nemoto,
  • Shota Kojima,
  • Tetsuya Sugiyama,
  • Denan Jin,
  • Shinji Takai,
  • Michiko Maeda,
  • Ryohsuke Kohmoto,
  • Mari Ueki,
  • Hidehiro Oku and
  • Tsunehiko Ikeda

Regorafenib eye drops were developed for treating age-related macular degeneration. This study aimed to investigate the effects of this multi-kinase inhibitor on intraocular pressure (IOP), bleb formation, and conjunctival changes in a canine filtrat...

of 6